Written by The Capillary Blood Collection Devices Market is developing alongside the broader shift toward decentralized diagnostics and patient-centered healthcare. These devices are used for collecting small blood samples for applications such as metabolic testing, diabetes monitoring, cardiovascular risk assessment, and neonatal screening. Market Research Future projects the market to grow at a 6.70% CAGR between 2026 and 2035.
Advances in microsampling are broadening the potential applications of capillary collection. Automated and safety-engineered lancets can improve collection convenience, while volumetric microsampling devices help standardize small sample volumes. Dried blood spot technologies are also creating opportunities in pharmacogenomics, remote testing, and decentralized clinical research.
Hospitals and clinics remained the leading end-user segment in 2025 with approximately 50.4% share. Lancing devices held about 44.8% of product revenue, while micro-container tubes generated approximately USD 0.58 billion. Genetic and neonatal screening is among the faster-growing applications as more healthcare systems expand screening programs.
North America accounted for approximately 42.3% of the global market in 2025. Europe followed with around 26.8%, while Asia-Pacific is expected to demonstrate faster expansion through 2035. Growth in home diagnostics, telehealth integration, neonatal screening, and point-of-care testing is likely to influence the market’s future development.
Gain a competitive edge with insightful market reports: